Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon
US7179465B2 · kind B2 · utility
16Cited by
13References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2004 |
| Grant date | Feb 20, 2007 |
| Priority date | — |
| Expiry date | May 18, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a monoclonal antibody directed against the human interferon class I receptor (IFN-R) characterized by the following properties: it recognizes the extracellular domain of the human IFN-R, and it has a neutralizing capacity against the biological properties of the human type I-IFN. It further concerns their use for the diagnosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.